‌

US Patent 10765682 Apilimod for use in the treatment of melanoma

Patent 10765682 was granted and assigned to AI Therapeutics on September, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

OrphAI Therapeutics

Current Assignee

OrphAI Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10765682

Date of Patent

September 8, 2020

Patent Application Number

15524841

Date Filed

November 6, 2015

Patent Citations

‌

US Patent 10206910 Apilimod for use in the treatment of renal cancer

‌

US Patent 10179135 Apilimod compositions and methods for using same

‌

US Patent 10350213 Methods for treating cancer using apilimod

Patent Citations Received

‌

US Patent 11266654 Apilimod compositions and methods for using same

Patent Primary Examiner

‌

My-Chau T. Tran

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10765682 Apilimod for use in the treatment of melanoma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API